Related Experiment Video
Updated: May 22, 2026

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
Published on: April 17, 2020
[3-year results of the SYNTAX trial--stent or surgery? A surgeon's perspective]
Lenard Conradi1, Hermann Reichenspurner
1Klinik und Poliklinik für Herz- und Gefäßchirurgie, Universitäres Herzzentrum Hamburg, Martinistrasse 52, Hamburg, Germany.
Insights
Coronary artery bypass grafting (CABG) is superior to percutaneous coronary intervention (PCI) for complex coronary artery disease. An interdisciplinary heart team should guide treatment decisions for these patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Cardiac Surgery
Context:
- Coronary artery bypass grafting (CABG) is the established treatment for complex coronary artery disease.
- Percutaneous coronary intervention (PCI) is increasingly used, even for advanced lesions.
- Clinical practice patterns diverge from established guidelines for myocardial revascularization.
Purpose:
- To compare the efficacy of CABG versus PCI in patients with three-vessel or left main coronary artery disease.
- To evaluate outcomes including repeat revascularization, myocardial infarction, and cardiac mortality.
- To emphasize the importance of interdisciplinary heart team decision-making for complex coronary lesions.
Summary:
- Large trials, including the SYNTAX trial, demonstrate CABG's superiority over PCI in advanced coronary artery disease.
- CABG showed better outcomes in terms of repeat revascularization, myocardial infarction, and cardiac mortality at 3-year follow-up.
- PCI remains a viable option for less complex left main coronary artery disease.
Impact:
- Confirms CABG as the preferred revascularization strategy for three-vessel and left main coronary artery disease.
- Highlights the necessity of formal, interdisciplinary heart team discussions for optimal patient management.
- Supports updated European Society of Cardiology guidelines on myocardial revascularization.
Abstract:
Coronary artery bypass grafting (CABG) is the standard of care for patients with three-vessel or left main coronary artery disease. However, clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by percutaneous coronary intervention (PCI) today. An abundancy of both large registries and randomized clinical trials has demonstrated superiority of surgery over PCI in advanced coronary artery disease. Recently, these results have been confirmed by the landmark SYNTAX trial where CABG was found to be superior to PCI for three-vessel and/or left main coronary artery disease regarding repeat revascularization, rate of myocardial infarction, and cardiac mortality at the latest follow-up of 3 years. On the other hand, PCI proved to be a viable alternative for less complex forms of left main disease.In conclusion, patients with three-vessel and/or left main coronary artery disease should be discussed in an interdisciplinary heart team consisting of cardiologists and cardiac surgeons within a heart center. Final decision making should be a formal process as recommended in the recently updated guidelines on myocardial revascularization by the European Society of Cardiology.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Mitral Stenosis III: Medical Management
